Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23290324 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Clinical Efficacy & Safety, of Metadoxine (MG01CI) Extended Release in Attention-Deficit Hyperactivity Disorder (ADHD)
Condition: ADHD
Intervention: Drug: Metadoxine (MG01CI)

Indicates status has not been verified in more than two years